MetaADEDB 2.0 @ LMMD
Noctran
(NXSHRUCPQPNTAW-UHFFFAOYSA-L)
Structure
SMILES
CC(N(C)C)CN1c2cc(ccc2Sc2c1cccc2)C(=O)C.[O-]C(=O)C1N=C(c2ccccc2)c2c(NC1=O)ccc(c2)Cl.CN(CCCN1c2ccccc2Sc2c1cc(cc2)C(=O)C)C.[K+].[K+].[OH-]
Molecular Formula:
C54H55ClK2N6O6S2
Molecular Weight:
1061.830
Log P:
9.6604
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
2
TPSA:
202.35
CAS Number(s):
78355-48-3
Synonym(s)
1.
Noctran
2.
FA 522 A
External Link(s)
MeSHC021314
PubChem Compound192141
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Altered state of consciousnessOFFSIDES
3Anti-erythropoietin antibody positiveOFFSIDES
4Antiviral drug level above therapeuticOFFSIDES
5Arterial thrombosisOFFSIDES
6AstheniaOFFSIDES
7Bladder stenosisOFFSIDES
8Blood sodiumOFFSIDES
9Body TemperatureOFFSIDES
10Bone fissureOFFSIDES
11BradycardiaOFFSIDES
12BronchopneumopathyOFFSIDES
13BulimiaOFFSIDES
14Cell DeathOFFSIDES
15CholangiolitisOFFSIDES
16Clostridium difficile colitisOFFSIDES
17Coagulation factor VIII level decreasedOFFSIDES
18ConfabulationOFFSIDES
19Creatinine renal clearance decreasedOFFSIDES
20Creatinine renal clearance increasedOFFSIDES
21Diabetes InsipidusOFFSIDES
22Drug abuserOFFSIDES
23Drug addictOFFSIDES
24Drug dispensing errorOFFSIDES
25Drug toxicityOFFSIDES
26Enterobacter sepsisOFFSIDES
27Epidermal necrosisOFFSIDES
28EpilepsyOFFSIDES
29EscharOFFSIDES
30Fatty LiverOFFSIDES
31Gamma-Glutamyltransferase IncreasedOFFSIDES
32General physical health deteriorationOFFSIDES
33Glasgow coma scaleOFFSIDES
34GranulocytosisOFFSIDES
35HepatitisOFFSIDES
36Histiocytosis haematophagicOFFSIDES
37HypoxiaOFFSIDES
38Kidney FailureOFFSIDES
39Leukopenia neonatalOFFSIDES
40Lichen PlanusOFFSIDES
41Malignant neoplasm progressionOFFSIDES
42Metabolic acidosisOFFSIDES
43Mucosal erosionOFFSIDES
44Muscle necrosisOFFSIDES
45PancreatitisOFFSIDES
46Physical disabilityOFFSIDES
47PneumoconiosisOFFSIDES
48Prealbumin decreasedOFFSIDES
49Pustular psoriasisOFFSIDES
50RalesOFFSIDES
51Respiratory tract congestionOFFSIDES
52Self-induced vomitingOFFSIDES
53Septic ShockOFFSIDES
54SigmoiditisOFFSIDES
55Skin lesionOFFSIDES
56Transaminases increasedOFFSIDES
57effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.